首页> 美国卫生研究院文献>Journal of Korean Medical Science >Coexistence of Chronic Lymphocytic Thyroiditis with Papillary Thyroid Carcinoma: Clinical Manifestation and Prognostic Outcome
【2h】

Coexistence of Chronic Lymphocytic Thyroiditis with Papillary Thyroid Carcinoma: Clinical Manifestation and Prognostic Outcome

机译:慢性淋巴细胞性甲状腺炎与乳头状甲状腺癌并存:临床表现和预后结果。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The study aimed to identify the clinical characteristics of coexisting chronic lymphocytic thyroiditis (CLT) in papillary thyroid carcinoma (PTC) and to evaluate the influence on prognosis. A total of 1,357 patients who underwent thyroid surgery for PTC were included. The clinicopathological characteristics were identified. Patients who underwent total thyroidectomy (n = 597) were studied to evaluate the influence of coexistent CLT on prognosis. Among the total 1,357 patients, 359 (26.5%) had coexistent CLT. In the CLT group, the prevalence of females was higher than in the control group without CLT (P < 0.001). Mean tumor size and mean age in the patients with CLT were smaller than without CLT (P = 0.040, P = 0.047, respectively). Extrathyroidal extension in the patients with CLT was significantly lower than without CLT (P = 0.016). Among the subset of 597 patients, disease-free survival rate in the patients with CLT was significantly higher than without CLT (P = 0.042). However, the multivariate analysis did not reveal a negative association between CLT coexistence and recurrence. Patients with CLT display a greater female preponderance, smaller size, younger and lower extrathyroidal extension. CLT is not a significant independent negative predictive factor for recurrence, although presence of CLT indicates a reduced risk of recurrence.
机译:该研究旨在确定乳头状甲状腺癌(PTC)中并存的慢性淋巴细胞性甲状腺炎(CLT)的临床特征,并评估其对预后的影响。总共纳入了1,357例行PTC甲状腺手术的患者。确定了临床病理特征。对行全甲状腺切除术(n = 597)的患者进行研究,以评估共存的CLT对预后的影响。在总共1357例患者中,有359例(26.5%)并存CLT。在CLT组中,女性患病率高于没有CLT的对照组(P <0.001)。有CLT的患者的平均肿瘤大小和平均年龄要小于没有CLT的患者(分别为P = 0.040,P = 0.047)。 CLT患者的甲状腺外扩张明显低于无CLT的患者(P = 0.016)。在597例患者中,CLT患者的无病生存率显着高于没有CLT的患者(P = 0.042)。但是,多变量分析并未显示CLT共存与复发之间存在负相关关系。 CLT患者表现出更大的女性优势,更小的体型,更年轻和更低的甲状腺外延伸。尽管CLT的存在表明复发风险降低,但CLT并不是复发的重要独立阴性预测因素。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号